Polymer Conjugated Retinoids for Controlled Transdermal Delivery

    July 2017 in “ Journal of controlled release ”
    Steven Castleberry, Mohiuddin Quadir, Malak Abu Sharkh, Kevin E. Shopsowitz, Paula T. Hammond
    TLDR A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.
    The study explored the use of polymer-conjugated all-trans retinoic acid (ATRA) for controlled transdermal delivery by conjugating ATRA to polyvinyl alcohol (PVA), creating a water-soluble amphiphilic nanomaterial (PATRA). This approach aimed to improve ATRA's stability, solubility, and retention while reducing side effects like skin irritation and hair loss. In vitro and ex vivo tests showed that PATRA provided sustained release and higher epidermal accumulation of ATRA, while in vivo tests on mice demonstrated reduced inflammation and prolonged drug retention. The findings suggested that PATRA could enhance the efficacy and safety of topical ATRA therapies.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community Looks like a real cure to the root of baldness (DHT-induced senescence) was proven earlier this year

      in Research/Science  742 upvotes 2 years ago
      A study that outlines the full model for androgenic alopecia (AGA) which links DHT to cellular senescence in dermal papilla cells, and suggests black chokeberry as a source of cyanidin 3-O-arabinoside polyphenol with potential anti-oxidant properties that could reverse this process. The post encourages reaching out to experts in anti-aging and longevity to research treatments involving the polyphenol.

      community DLQ01: A Better "Minoxidil" PGF2a synthetic analogue.

      in Research/Science  3 upvotes 1 month ago
      DLQ01, a prostaglandin F2α analog, shows promise for hair growth by directly stimulating PGE2/PGF receptors without needing conversion, and can be combined with minoxidil and retinoids like tretinoin for enhanced effectiveness. Minoxidil's efficacy may be reduced by COX-1 inhibitors, but using prostaglandin analogs like Latanoprost or Bimatoprost can help maintain its effectiveness.

      community Painkillers May Block Minoxidil

      in Research/Science  12 upvotes 2 weeks ago
      Painkillers like Aspirin may reduce Minoxidil's effectiveness by inhibiting the enzyme PGHS-1, which is crucial for hair growth. Using NSAIDs that inhibit COX-2 or combining Minoxidil with PGF2/E2 analogues or retinoids may enhance its efficacy.

      community Dutasteride for trans men? (Topical vs oral?)

      in Transgender 5 months ago
      The conversation discusses using dutasteride, both topical and oral, for hair loss in trans men, considering potential side effects like depression and libido issues. The user is exploring options including topical solutions with minoxidil, retinoic acid, and hydrocortisone, and plans to start microneedling.

      community Haircafe - TOPICAL minoxidil is an anti aging drug

      in Minoxidil  248 upvotes 3 months ago
      Topical minoxidil may cause skin aging effects like wrinkles and dark circles, possibly due to its alcohol content, while oral finasteride is reported to make users look younger. Switching to oral minoxidil or using moisturizers might help reduce these skin issues.

    Similar Research

    5 / 1000+ results